-
Vortrag
Analysis of Blood Pressure Following Short-Term and Long-Term Treatment with Erenumab
Autor:in
Datum:
18.10.2018 ,
Zeit:
14:15
|
Thema:
Details
-
Vortrag
Analysis of Injection Site Reactions across Four Placebo Controlled Trials of Erenumab for Migraine Prevention
Autor:in
Datum:
18.10.2018 ,
Zeit:
14:21
|
Thema:
Details
-
Vortrag
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients with Stable Angina
Speaker
Datum:
18.10.2018 ,
Zeit:
14:27
|
Thema:
Details
-
Vortrag
Efficacy of erenumab for the treatment of patients with episodic migraine with aura
Speaker
Datum:
18.10.2018 ,
Zeit:
14:33
|
Thema:
Details
-
Vortrag
Efficacy of erenumab for the treatment of patients with episodic migraine with depression and/or anxiety
Autor:in
Datum:
18.10.2018 ,
Zeit:
14:39
|
Thema:
Details
-
Vortrag
Efficacy of Erenumab in Women With and Without a History of Menstrually-Related Migraine
Autor:in
Datum:
18.10.2018 ,
Zeit:
14:45
|
Thema:
Details
-
Vortrag
Erenumab Immunogenicity: A Pooled Analysis of Phase 2 and Phase 3 Migraine Prevention Clinical Trials
Autor:in
Datum:
18.10.2018 ,
Zeit:
14:51
|
Thema:
Details
-
Vortrag
Erenumab Safety Among Migraine Patients Using Triptans or With Cardiovascular (CV) Risk Factors
Autor:in
Datum:
18.10.2018 ,
Zeit:
14:39
|
Thema:
Details